Lauppe, Rosa, Fredrik O. L. Nilsson, Hanna Fues Wahl, Mathias Lilja, Anders Vikström, and Sandra T. Asanin. “Use of ALK-Tyrosine Kinase Inhibitors (ALK TKI) in Clinical Practice, Overall Survival, and Treatment Duration – a Swedish Nationwide Retrospective Study”. Acta Oncologica 61, no. 11 (November 2, 2022): 1354–1361. Accessed June 18, 2026. https://medicaljournalssweden.se/actaoncologica/article/view/23842.